BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Fenofibrate
,
rs2476601
,
MDM2
,
Angiogenesis
,
Allergy to pollen
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
L1 1
Summary
General Info
Curated Studies
Most Correlated Studies
Adipocytes cell lines C3H/10T1/2 and 3T3 L1 treated with Rosiglitazone
Adipocyte profiling analyses of Selective PPARg Modulators and full PPARg agonists
Preadipocytes from 3T3-L1 fibroblasts induced with adipogenic drugs for 4hr to become adipocytes
Adipocytes derived from preadipocyte 3T3-L1 cells with an adipogenic induction cocktail
Blood monocytes treated with various inflammatory stimuli
Explore Curated Studies Results
Literature
Most Relevant Literature
Whole-genome sequencing of Mycobacterium tuberculosis sublineage L1.1.1.7 from Chiangrai, Thailand.
Ethanol and H2O2 stresses enhance lipid production in an oleaginous Rhodotorula toruloides thermotol…
L1.2, the zebrafish paralog of L1.1 and ortholog of the mammalian cell adhesion molecule L1 contribu…
Donor free stibenium cation as an efficient cyanosilylation catalyst.
Tetracoordinated 15-Electron Ruthenium(I) in a Discrete Triruthenium Framework.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locall…
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ